7.25
price up icon0.00%   0.00
 
loading
Mimedx Group Inc stock is traded at $7.25, with a volume of 388.37K. It is up +0.00% in the last 24 hours and up +2.11% over the past month. MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
See More
Previous Close:
$7.25
Open:
$7.2
24h Volume:
388.37K
Relative Volume:
0.46
Market Cap:
$1.05B
Revenue:
$342.81M
Net Income/Loss:
$97.67M
P/E Ratio:
11.80
EPS:
0.6145
Net Cash Flow:
$50.46M
1W Performance:
+3.87%
1M Performance:
+2.11%
6M Performance:
+23.93%
1Y Performance:
-23.92%
1-Day Range:
Value
$7.04
$7.2815
1-Week Range:
Value
$6.99
$7.37
52-Week Range:
Value
$5.79
$9.71

Mimedx Group Inc Stock (MDXG) Company Profile

Name
Name
Mimedx Group Inc
Name
Phone
(770) 651-9100
Name
Address
1775 W OAK COMMONS COURT, NE, MARIETTA
Name
Employee
837
Name
Twitter
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
MDXG's Discussions on Twitter

Compare MDXG with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
6.49 0 0 0 0 0.00
 icon
MOBBW
Mobilicom Limited Warrants
3.465 4.55B 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
20.64 372.90M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
4.555 300.23M 2.07B -1.42B -1.37B -0.6765
 icon
SHMD
Schmid Group N V
4.4939 203.25M 0 0 0 0.00
 icon
DAVEW
Dave Inc
0.70 0 0 0 0 0.00

Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-02-24 Initiated Cantor Fitzgerald Overweight
Mar-07-24 Initiated Lake Street Buy
Oct-27-23 Initiated Craig Hallum Buy
Oct-13-22 Initiated Mizuho Buy
Jul-26-21 Initiated Northland Capital Outperform
Mar-19-21 Initiated H.C. Wainwright Buy
View All

Mimedx Group Inc Stock (MDXG) Latest News

pulisher
09:12 AM

MiMedx Group (NASDAQ:MDXG) Price Target Lowered to $10.00 at Mizuho - MarketBeat

09:12 AM
pulisher
07:50 AM

MiMedx price target lowered to $10 from $12 at Mizuho - TipRanks

07:50 AM
pulisher
Dec 15, 2025

Is MiMedx Group, Inc.'s (NASDAQ:MDXG) Recent Stock Performance Tethered To Its Strong Fundamentals? - simplywall.st

Dec 15, 2025
pulisher
Dec 08, 2025

Divisadero Street Capital Management LP Boosts Stock Position in MiMedx Group, Inc $MDXG - MarketBeat

Dec 08, 2025
pulisher
Dec 06, 2025

Trigran Investments Inc. Has $51.27 Million Holdings in MiMedx Group, Inc $MDXG - MarketBeat

Dec 06, 2025
pulisher
Dec 05, 2025

MiMedx Group (MDXG) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 05, 2025
pulisher
Dec 04, 2025

Why MiMedx Group Inc. stock remains undervaluedWeekly Trade Analysis & Proven Capital Preservation Tips - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How currency fluctuations impact MiMedx Group Inc. stockJuly 2025 Rallies & Intraday High Probability Alerts - Newser

Dec 04, 2025
pulisher
Dec 01, 2025

Geode Capital Management LLC Decreases Stock Holdings in MiMedx Group, Inc $MDXG - MarketBeat

Dec 01, 2025
pulisher
Nov 29, 2025

Can MiMedx Group Inc. stock maintain operating margins2025 Dividend Review & Precise Swing Trade Alerts - BỘ NỘI VỤ

Nov 29, 2025
pulisher
Nov 28, 2025

MiMedx announces publication of interim results from CAMPAIGN trial - MSN

Nov 28, 2025
pulisher
Nov 27, 2025

Will MiMedx Group Inc. stock gain from lower inflationTrade Exit Summary & Growth Oriented Trading Recommendations - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 23, 2025

MiMedx Group Inc. Reports Record Q3 Revenue - MSN

Nov 23, 2025
pulisher
Nov 22, 2025

MiMedx Group (MDXG) Is Down 8.4% After Strong CAMPAIGN Trial Results for EPIEFFECT Product – What's Changed - simplywall.st

Nov 22, 2025
pulisher
Nov 21, 2025

Is MiMedx Group Inc. stock attractive for long term wealth building - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is MiMedx Group Inc. stock a good choice for value investors2025 Retail Activity & Weekly Stock Breakout Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will MiMedx Group Inc. stock maintain dividend yieldFed Meeting & Smart Money Movement Tracker - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Can MiMedx Group Inc. stock sustain market leadershipJuly 2025 Action & Technical Pattern Based Buy Signals - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Is MiMedx Group Inc. showing signs of accumulationVolume Spike & Pattern Based Trade Signal System - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will MiMedx Group Inc. stock go up soon2025 Historical Comparison & Risk Managed Trade Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will MiMedx Group Inc. stock recover faster than peersJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

MiMedx Group (NASDAQ:MDXG) Stock Price Down 5.6%What's Next? - MarketBeat

Nov 19, 2025
pulisher
Nov 18, 2025

How Mimedx Group Inc (MDXG) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Nov 18, 2025
pulisher
Nov 18, 2025

MiMedx (MDXG) Just Flashed Golden Cross Signal: Do You Buy? - sharewise.com

Nov 18, 2025
pulisher
Nov 16, 2025

Is MiMedx Group Inc. stock attractive for ETFsBond Market & AI Driven Price Forecasts - newser.com

Nov 16, 2025
pulisher
Nov 14, 2025

Using data models to predict MiMedx Group Inc. stock movement2025 Big Picture & Technical Buy Zone Confirmations - newser.com

Nov 14, 2025

Mimedx Group Inc Stock (MDXG) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$38.55
price up icon 0.40%
$97.59
price up icon 0.76%
$31.82
price up icon 1.37%
$92.87
price up icon 0.67%
biotechnology ONC
$305.25
price down icon 0.24%
$200.80
price down icon 0.06%
Cap:     |  Volume (24h):